Metabolic effects of aldose reductase inhibition during low-flow ischemia and reperfusion.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  1998-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1152/ajpheart.1998.275.1.H195PMID 29586607
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Methods of Enzymatic Analysis

  2019cited by this paper
• Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts.

  1998cited by this paper
• Exercise training increases sarcolemmal GLUT-4 protein and mRNA content in diabetic heart.

  1997cited by this paper
• Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions.

  1997cited by this paper
• Aldose Reductase Inhibition Protects Diabetic and Nondiabetic Rat Hearts from Ischemic Injury

  1997cited by this paper
• Glycogen utilization and ischemic injury in the isolated rat heart.

  1997cited by this paper
• Short-term inhibition of the Na-H exchanger limits acidosis and reduces ischemic injury in the rat heart.

  1997cited by this paper
• Mechanisms of Intracellular pH Regulation During Postischemic Reperfusion of Diabetic Rat Hearts

  1995influential reference
• Role of High Glycogen in Underperfused Diabetic Rat Hearts with Added Norepinephrine

  1995cited by this paper
• Ischemic preconditioning stimulates sodium and proton transport in isolated rat hearts.

  1995cited by this paper
• Effects of glycogen depletion on ischemic injury in isolated rat hearts: insights into preconditioning.

  1995cited by this paper
• The role of Na+/K+ ATPase activity during low flow ischemia in preventing myocardial injury: A 31P, 23Na and 87Rb NMR spectroscopic study

  1995cited by this paper
• Requirement of glycolytic substrate for metabolic recovery during moderate low flow ischemia.

  1995cited by this paper
• The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.

  1994cited by this paper
• Myocardial glucose transporters and glycolytic metabolism during ischemia in hyperglycemic diabetic swine.

  1994cited by this paper
• Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion.

  1994influential reference
• The relative importance of myocardial energy metabolism compared with ischemic contracture in the determination of ischemic injury in isolated perfused rabbit hearts.

  1994cited by this paper
• Mechanisms of pHi recovery after global ischemia in the perfused heart.

  1993cited by this paper
• Aldose reductase inhibitors: recent developments.

  1993cited by this paper
• Hyperglycemic Pseudohypoxia and Diabetic Complications

  1993influential reference
• Regulation of intracellular pH in the perfused heart by external HCO3- and Na(+)-H+ exchange.

  1993cited by this paper
• A 13C-NMR study of glucose oxidation in the intact functioning rat heart following diabetes-induced cardiomyopathy.

  1993cited by this paper
• Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy.

  1993cited by this paper
• Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle.

  1992cited by this paper
• Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic acid (zopolrestat) and congeners.

  1991cited by this paper
• Protons in ischemia: where do they come from; where do they go to?

  1991cited by this paper
• The Gibbs-Donnan near-equilibrium system of heart.

  1990cited by this paper
• Na+ accumulation increases Ca2+ overload and impairs function in anoxic rat heart.

  1990cited by this paper
• Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts.

  1990cited by this paper
• Role of Intracellular Na+ in Ca2+ Overload and Depressed Recovery of Ventricular Function of Reperfused Ischemic Rat Hearts Possible Involvement of H+-Na+ and Na+-Ca2+ Exchange

  1989cited by this paper
• Adenine Nucleotide Metabolism in Hearts of Diabetic Rats: Comparison to Diaphragm, Liver, and Kidney

  1988cited by this paper
• Functional compartmentation of glycolytic versus oxidative metabolism in isolated rabbit heart.

  1985cited by this paper
• Aldose reductase, NADPH and NADP+ in normal, galactose-fed and diabetic rat lens.

  1985cited by this paper
• Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Effects on contractile function, diastolic compliance, metabolism, and ultrastructure during ischemia and reperfusion.

  1983cited by this paper
• Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart.

  1981cited by this paper
• Red Cell Sorbitol: An Indicator of Diabetic Control

  1980cited by this paper
• Studies of acidosis in the ischaemic heart by phosphorus nuclear magnetic resonance.

  1979cited by this paper
• The heart in diabetes mellitus.

  1979cited by this paper
• The heart in diabetes mellitus. Part I. Biochemical basis for myocardial dysfunction.

  1979cited by this paper
• Effect of glucose-insulin-potassium infusions on arteriovenous differences of glucose and of free fatty acids and on tissue metabolic changes in dogs with developing myocardial infarction

  1976cited by this paper
• Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease.

  1975cited by this paper
• Metabolic responses to varying restrictions of coronary blood flow in swine.

  1975cited by this paper
• Mechanisms of Glycolytic Inhibition in Ischemic Rat Hearts

  1975cited by this paper
• Effects of Glucose, Insulin and Potassium Infusion on Tissue Metabolic Changes Within First Hour of Myocardial Infarction in the Baboon

  1975cited by this paper

• Oxidative stress-mediated protein sulfenylation in human diseases: Past, present, and future

  2024cites this paper
• Rationale and Design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in Patients with High-Risk Diabetic Cardiomyopathy.

  2022cites this paper
• COVID-19 and the Heart and Vasculature

  2020cites this paper
• Cardiospecific Overexpression of ATPGD1 (Carnosine Synthase) Increases Histidine Dipeptide Levels and Prevents Myocardial Ischemia Reperfusion Injury

  2020cites this paper
• Novel approaches to reduce virus-induced inflammation in patients with cardiovascular disease

  2020cites this paper
• Glucose Metabolism in Cardiac Hypertrophy and Heart Failure

  2019cites this paper
• Inhibition of aldose reductase activity stimulates starvation induced autophagy and clears aldehyde protein adducts.

  2019cites this paper
• Pyridine Dinucleotides from Molecules to Man

  2018cites this paper
• Myocardial Infarction: Disease Mechanisms and Therapeutic Perspectives

  2017cites this paper
• Aldose reductase (AKR1B) deficiency promotes phagocytosis in bone marrow derived mouse macrophages.

  2017cites this paper
• Protective role of fructokinase blockade in the pathogenesis of acute kidney injury in mice

  2017cites this paper
• Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways.

  2016cites this paper
• NAD+ as the Link Between Oxidative Stress, Inflammation, Caloric Restriction, Exercise, DNA Repair, Longevity, and Health Span

  2016cites this paper
• NAD+ in Cancer Prevention and Treatment: Pros and Cons

  2016cites this paper
• Sorbitol dehydrogenase inhibitor protects the liver from ischemia/reperfusion-induced injury via elevated glycolytic flux and enhanced sirtuin 1 activity.

  2015cites this paper
• Cardiovascular Consequences of Obesity and Type 2 Diabetes Damaging effects of hyperglycemia on cardiovascular function : spotlight on glucose metabolic pathways

  2015cites this paper
• Cardiovascular Function: Spotlight on Glucose

  2015cites this paper
• Detrimental effects of acute hyperglycaemia on the rat heart

  2014cites this paper
• Characterization of the mitochondrial genomes of Diuraphis noxia biotypes

  2014cites this paper
• Aldose Reductase and Diabetic Cardiovascular Disease

  2014cites this paper
• İZOLE SIÇAN KALBİNDE İSKEMİ REPERFÜZYON HASARINA BAĞLI OLUŞAN HEMODİNAMİK YANITLARA YÜKSEK FRUKTOZLU VE YÜKSEK GLUKOZLU DİYETİN ETKİSİ

  2014cites this paper
• Diabetes and Cardiac Mitochondria

  2013cites this paper
• Role of Aldose Reductase in the Metabolism and Detoxification of Carnosine-Acrolein Conjugates*

  2013cites this paper
• Pyridine Nucleotide Regulation of Cardiac Intermediary Metabolism Sirtuins and Pyridine Nucleotides Regulation of Ion Channels by Pyridine Nucleotides The Role of NADPH in Antioxidant Scavenging

  2012cites this paper
• Aldose reductase, oxidative stress and diabetic cardiovascular complications.

  2012cites this paper
• Aldose reductase modulates cardiac glycogen synthase kinase-3β phosphorylation during ischemia-reperfusion.

  2012cites this paper
• Amelioration of Acute Kidney Injury in Lipopolysaccharide-Induced Systemic Inflammatory Response Syndrome by an Aldose Reductase Inhibitor, Fidarestat

  2012cites this paper
• Pyridine nucleotide regulation of cardiac intermediary metabolism.

  2012cites this paper
• Molecular and Cellular Signaling Mechanisms Elucidating Aldose Reductase Mediated Ischemia-Reperfusion Injury in the Myocardium

  2012cites this paper
• NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns

  2012cites this paper
• The Redox Basis of Epigenetic Modifications: From Mechanisms to Functional Consequences

  2011cites this paper
• Aldose reductase pathway contributes to vulnerability of aging myocardium to ischemic injury.

  2011cites this paper
• Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model.

  2010cites this paper
• The role of the polyol pathway in acute kidney injury caused by hindlimb ischaemia in mice

  2010cites this paper
• Anti‐ischaemic activity of an antioxidant aldose reductase inhibitor on diabetic and non‐diabetic rat hearts

  2010cites this paper
• Polyol pathway impairs the function of SERCA and RyR in ischemic-reperfused rat hearts by increasing oxidative modifications of these proteins.

  2010cites this paper
• The anti-necrosis role of hypoxic preconditioning after acute anoxia is mediated by aldose reductase and sorbitol pathway in PC12 cells

  2010cites this paper
• Protective Effect of Squalene on Mitochondrial Alterations in Isoprenaline-Induced Myocardial Injury

  2010cites this paper
• Polyol pathway and RAGE: a central metabolic and signaling axis in diabetic complications

  2010cites this paper
• Advanced Glycation End Products, RAGE, and Aging

  2010cites this paper
• Papel del factor transcripcional TonEBP en el daño cardíaco inducido por hiperosmolaridad

  2009influential citation
• Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.

  2009cites this paper
• Atorvastatin reduces the expression of aldo-keto reductases in HUVEC and PTEC. A new approach to influence the polyol pathway.

  2009cites this paper
• Therapeutic potential of sulindac against ischemia-reperfusion-induced myocardial infarction in diabetic and nondiabetic rats.

  2008cites this paper
• Polyol pathway mediates iron-induced oxidative injury in ischemic-reperfused rat heart.

  2008cites this paper
• Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts

  2008cites this paper
• Neurodegeneration and Inflammation.

  2008cites this paper
• Pyridine Nucleotide Redox Abnormalities in Diabetes

  2007cites this paper
• Atorvastatin Donor Pretreatment Prevents Ischemia/Reperfusion Injury in Renal Transplantation in Rats: Possible Role for Aldose-Reductase Inhibition

  2007cites this paper
• MODIFICACIÓN DE PROTEÍNAS POR LÍPIDOS ELECTRÓFILOS: SELECTIVIDAD

  2007cites this paper
• Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets.

  2006cites this paper
• Aldose reductase inhibitors improve myocardial reperfusion injury in mice by a dual mechanism.

  2006cites this paper
• WY 14,643 inhibits human aldose reductase activity

  2006cites this paper
• Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.

  2005cites this paper
• Aldose Reductase and AGE‐RAGE Pathways: Key Players in Myocardial Ischemic Injury

  2005cites this paper
• Aldose reductase pathway mediates JAK‐STAT signaling: a novel axis in myocardial ischemic injury

  2005cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL INSTITUTO DE CIÊNCIAS BIOLÓGICAS PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS BIOLÓGICAS - BIOQUÍMICA EFEITO DE COMPOSTOS ORGANOCALCOGÊNIOS E DO EXERCÍCIO FÍSICO EM DOIS MODELOS EXPERIMENTAIS DE

  2005cites this paper
• Heart Failure and Cardiac Dysfunction in Diabetes

  2005cites this paper
• Coregulators and chromatin remodeling in transcriptional control

  2004cites this paper
• RAGE and its ligands: a lasting memory in diabetic complications?

  2004cites this paper
• Metabolic and Functional Protection by Selective Inhibition of Nitric Oxide Synthase 2 During Ischemia-Reperfusion in Isolated Perfused Hearts

  2004cites this paper
• Central role for aldose reductase pathway in myocardial ischemic injury

  2004cites this paper
• LPS-Induced Changes in Myocardial Markers in Neonatal Rats

  2003cites this paper
• Sorbitol dehydrogenase: a novel target for adjunctive protection of ischemic myocardium

  2003influential citation
• Glycation, Inflammation, and RAGE: A Scaffold for the Macrovascular Complications of Diabetes and Beyond

  2003cites this paper
• Role of Lipid Peroxidation in Myocardial Ischemic Injury

  2003cites this paper
• Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease.

  2003cites this paper
• Quantitative gas chromatographic-mass spectrometric assay of 4-hydroxynonenal bound to thiol proteins in ischemic/reperfused rat hearts.

  2002cites this paper
• Relative importance of enhanced glucose uptake versus attenuation of long-chain acyl carnitines in protecting ischemic myocardium

  2002cites this paper
• Aldose reductase activation is a key component of myocardial response to ischemia

  2002cites this paper
• Protection of ischemic myocardium in diabetics by inhibition of electroneutral Na+-K+-2Cl- cotransporter.

  2001cites this paper
• Evidence of separate pathways for lactate uptake and release by the perfused rat heart.

  2001cites this paper
• Protection of ischemic hearts perfused with an anion exchange inhibitor, DIDS, is associated with beneficial changes in substrate metabolism.

  2001cites this paper
• Heart Failure in Diabetic Patients

  2001cites this paper
• Protection of ischemic hearts by high glucose is mediated, in part, by GLUT-4.

  2001influential citation
• Niacin protects the isolated heart from ischemia-reperfusion injury.

  2000cites this paper
• Fructose‐2,6‐bisphosphate, a potent stimulator of phosphofructokinase, is increased by high exogenous glucose perfusion

  2000cites this paper
• Aldose reductase inhibition alone or combined with an adenosine A(3) agonist reduces ischemic myocardial injury.

  2000cites this paper
• New insights on myocardial pyridine nucleotides and thiol redox state in ischemia and reperfusion damage.

  2000cites this paper
• Preferential inhibition of lactate oxidation relative to glucose oxidation in the rat heart following diabetes.

  1999cites this paper
• Attenuation of ischemia induced increases in sodium and calcium by the aldose reductase inhibitor zopolrestat.

  1999cites this paper